Research summary, original research, 2024

Cancer Risks in U.S. Radiologic Technologists Working with Fluoroscopically Guided Interventional Procedures, 1994-2008

Rajaraman P, Doody MM, Yu CL, Preston DL, Miller JS, Sigurdson AJ, et al.. AJR. American journal of roentgenology. 2024

Read the original paper

In plain language

In about 91,000 US radiologic technologists, those who worked with fluoroscopically guided procedures had higher brain cancer mortality and modestly higher breast cancer and melanoma incidence. Overall cancer mortality was not raised. This is an association without dose data, so chance or confounding cannot be excluded.

At a glance

Type of study
Original research, Prospective cohort study
Who was studied
Radiologic technologists
Size
n = 90,957 radiologic technologists
Where
United States
Summary based on
the full text

What it found

  • Brain cancer mortality was about twofold higher in technologists who ever worked with fluoroscopically guided interventional procedures than in those who never did, based on 26 exposed cases.

    Key figures: HR, 2.55; 95% confidence interval (CI), 1.48-4.40

  • Female breast cancer incidence was modestly elevated, but breast cancer mortality was not.

    Key figures: Incidence HR, 1.16; 95% CI, 1.02-1.32; mortality HR, 1.07; 95% CI, 0.69-1.66

  • Melanoma incidence was modestly elevated among technologists who worked with these procedures.

    Key figures: HR, 1.30; 95% CI, 1.05-1.61

  • Mortality from all cancers combined was not elevated, with only a small suggestive increase in all-cancer incidence.

    Key figures: Mortality HR, 1.00; 95% CI, 0.88-1.14; incidence HR, 1.08; 95% CI, 1.00-1.17

  • No elevated risk was seen for thyroid, nonmelanoma skin, prostate, lung or colorectal cancer, or for non-CLL leukemia.

Limits to keep in mind

Exposure was a self-reported ever/never measure with no individual dose data, some incident cancers were self-reported and not validated, and residual confounding is possible. Follow-up was short relative to cancer latency and there were few brain cancer cases.

How this summary was made

ORSIF prepared this summary with AI assistance from the full text of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.

Prepared November 3, 2026.